PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain

<p><span style="font-weight: 400;">In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. </span></p> <p><span style= "font-weight: 400;">www.psychedelicstoday.com</span></p>